ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630734; 2) Community: the network communities that were significantly associated with the response to NSC 630734; 3) Molecule: the relationships between components within communities and NSC 630734; 4) MDR: the compounds that were significantly associated with the NSC 630734.

NSC Compound Enrichment Correlation
NSC 686368 Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- 0.0303322639291196 -0.19237805
NSC 368697 Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- 0.0303322639291198 0.29738317
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0303322639291198 0.24219748
NSC 665759 Null 0.0303322639291198 0.029536516
NSC 670162 Phosphonium, 1,8-octanediylbis[triphenyl-, diiodide 0.0303322639291198 0.030195064
NSC 19441 FDA 0283 0.0337307532806863 0.096830692
NSC 2626 Tenox PG 0.0337307532806863 -0.087566264
NSC 348402 Null 0.0337307532806863 0.13979198
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.0337307532806863 -0.083330376
NSC 5355 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) 0.0337307532806863 0.21893021
Total:49  Current:31    [First] [Prev] [Next] [Last]